drugset / Trial / NCT01071135
Quetiapine XR in Schizophrenic Patients
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of the study is to determine the effect of Quetiapine in patients with schizophrenia induced by cannabis abuse.
Timeline
- Start
- 2009-09
- Primary completion
- 2010-08
- Completion
- 2010-08
Outcome
Outcome not reported
Stopped (Enrollment): “Planned number of 30 subjects could not be recruited during recruitment phase.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Quetiapine | Small molecule | 400 mg | Oral |
| Subject | Quetiapine | Small molecule | 800 mg | Oral |